# Efficacy of Adding Dexmedetomidine as an Adjuvant to Bupivacaine in TAP Block and Caudal Block

> **NCT04926454** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 50 (estimated)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT04926454
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-22
- **Primary completion:** 2021-10-25
- **Final completion:** 2021-10-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04926454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04926454, "Efficacy of Adding Dexmedetomidine as an Adjuvant to Bupivacaine in TAP Block and Caudal Block". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT04926454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*